Does Tirzepatide Cause Hair Loss? What the Zepbound Label Says, and What Helps
Hair loss is a listed side effect of tirzepatide. In the weight-loss trials behind Zepbound, hair loss was reported in about 4 to 5% of people taking it, compared with 1% on placebo, and it was much more common in women: 7.1% versus 0.5% of men, according to the Zepbound prescribing information. Mounjaro is the same drug, sold for type 2 diabetes.
The label notes the hair loss was associated with weight reduction, which points to telogen effluvium: temporary shedding after a big change to the body. Below is what the numbers mean, what helps, and when to talk to your prescriber.
MH



